APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Imaging Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nuclear Medicine Imaging Agents Industry Growth and Trends Forecast to 2032

25 December 2025106 pages

Choose your research edition.

Industry ResearchNuclear Medicine Imaging Agents Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Imaging Agents Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Imaging Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Imaging Agents Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Imaging Agents Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Imaging Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nuclear Medicine Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nuclear Medicine Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Medicine Imaging Agents include Jubilant Pharma Limited, Foshan Rui Diao Pharmaceutical, Yantai Dongcheng, Navidea, Mallinckrodt, Lantheus, Guerbet, GE HealthCare and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nuclear Medicine Imaging Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nuclear Medicine Imaging Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nuclear Medicine Imaging Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nuclear Medicine Imaging Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nuclear Medicine Imaging Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nuclear Medicine Imaging Agents Market by Company

Jubilant Pharma Limited

Foshan Rui Diao Pharmaceutical

Yantai Dongcheng

Navidea

Mallinckrodt

Lantheus

Guerbet

GE HealthCare

Eli Lilly and Company

Cardinal Health

Bracco Diagnostic

Blue Earth Diagnostics

Bayer AG

Abx Advanced Biochemical

Nuclear Medicine Imaging Agents Segment by Type

Nitrogen 13 Labeling

Technetium 99 Labeling

Fluorine 18 Labeling

Carbon 11 Labeling

Oxygen 15 Labeling

Others

Nuclear Medicine Imaging Agents Segment by Application

Clinical Stage

Early Diagnosis

Treatment Evaluation

Nuclear Medicine Imaging Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Imaging Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Imaging Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Imaging Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclear Medicine Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nuclear Medicine Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nitrogen 13 Labeling Table 2. Major Company of Technetium 99 Labeling Table 3. Major Company of Fluorine 18 Labeling Table 4. Major Company of Carbon 11 Labeling Table 5. Major Company of Oxygen 15 Labeling Table 6. Major Company of Others Table 7. Global Nuclear Medicine Imaging Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 9. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type (2021-2026) Table 10. Global Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 11. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Type (2021-2026) Table 12. Global Nuclear Medicine Imaging Agents Price by Type (2021-2026) & (US$/Unit) Table 13. Global Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (K Units) Table 14. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type (2027-2032) Table 15. Global Nuclear Medicine Imaging Agents Sales by Type (2027-2032) & (US$ Million) Table 16. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Type (2027-2032) Table 17. Global Nuclear Medicine Imaging Agents Price by Type (2027-2032) & (US$/Unit) Table 18. North America Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 19. North America Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 21. Europe Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 25. Latin America Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Type (2021-2026) & (US$ Million) Table 28. Nuclear Medicine Imaging Agents Industry Trends Table 29. Nuclear Medicine Imaging Agents Industry Drivers Table 30. Nuclear Medicine Imaging Agents Industry Opportunities and Challenges Table 31. Nuclear Medicine Imaging Agents Industry Restraints Table 32. Global Nuclear Medicine Imaging Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Nuclear Medicine Imaging Agents Revenue Market Share by Company (2021-2026) Table 34. Global Nuclear Medicine Imaging Agents Sales by Company (2021-2026) & (K Units) Table 35. Global Nuclear Medicine Imaging Agents Sales Share by Company (2021-2026) Table 36. Global Nuclear Medicine Imaging Agents Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Nuclear Medicine Imaging Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Nuclear Medicine Imaging Agents Major Company Production Sites and Headquarters Table 39. Global Nuclear Medicine Imaging Agents Company, Product Type & Application Table 40. Global Nuclear Medicine Imaging Agents Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Nuclear Medicine Imaging Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Nuclear Medicine Imaging Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Nuclear Medicine Imaging Agents Sales by Region (2021-2026) & (K Units) Table 45. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Region (2021-2026) Table 46. Global Nuclear Medicine Imaging Agents Sales by Region (2021-2026) & (US$ Million) Table 47. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Region (2021-2026) Table 48. Global Nuclear Medicine Imaging Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Nuclear Medicine Imaging Agents Sales by Region (2027-2032) & (K Units) Table 50. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Region (2027-2032) Table 51. Global Nuclear Medicine Imaging Agents Sales by Region (2027-2032) & (US$ Million) Table 52. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Region (2027-2032) Table 53. Global Nuclear Medicine Imaging Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Nuclear Medicine Imaging Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 56. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application (2021-2026) Table 57. Global Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 58. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Application (2021-2026) Table 59. Global Nuclear Medicine Imaging Agents Price by Application (2021-2026) & (US$/Unit) Table 60. Global Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (K Units) Table 61. Global Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application (2027-2032) Table 62. Global Nuclear Medicine Imaging Agents Sales by Application (2027-2032) & (US$ Million) Table 63. Global Nuclear Medicine Imaging Agents Sales Market Share in Value by Application (2027-2032) Table 64. Global Nuclear Medicine Imaging Agents Price by Application (2027-2032) & (US$/Unit) Table 65. North America Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 66. North America Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 68. Europe Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 72. Latin America Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Application (2021-2026) & (US$ Million) Table 75. Jubilant Pharma Limited Company Information Table 76. Jubilant Pharma Limited Business Overview Table 77. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolio Table 79. Jubilant Pharma Limited Recent Development Table 80. Foshan Rui Diao Pharmaceutical Company Information Table 81. Foshan Rui Diao Pharmaceutical Business Overview Table 82. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolio Table 84. Foshan Rui Diao Pharmaceutical Recent Development Table 85. Yantai Dongcheng Company Information Table 86. Yantai Dongcheng Business Overview Table 87. Yantai Dongcheng Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolio Table 89. Yantai Dongcheng Recent Development Table 90. Navidea Company Information Table 91. Navidea Business Overview Table 92. Navidea Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Navidea Nuclear Medicine Imaging Agents Product Portfolio Table 94. Navidea Recent Development Table 95. Mallinckrodt Company Information Table 96. Mallinckrodt Business Overview Table 97. Mallinckrodt Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolio Table 99. Mallinckrodt Recent Development Table 100. Lantheus Company Information Table 101. Lantheus Business Overview Table 102. Lantheus Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Lantheus Nuclear Medicine Imaging Agents Product Portfolio Table 104. Lantheus Recent Development Table 105. Guerbet Company Information Table 106. Guerbet Business Overview Table 107. Guerbet Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Guerbet Nuclear Medicine Imaging Agents Product Portfolio Table 109. Guerbet Recent Development Table 110. GE HealthCare Company Information Table 111. GE HealthCare Business Overview Table 112. GE HealthCare Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. GE HealthCare Nuclear Medicine Imaging Agents Product Portfolio Table 114. GE HealthCare Recent Development Table 115. Eli Lilly and Company Company Information Table 116. Eli Lilly and Company Business Overview Table 117. Eli Lilly and Company Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolio Table 119. Eli Lilly and Company Recent Development Table 120. Cardinal Health Company Information Table 121. Cardinal Health Business Overview Table 122. Cardinal Health Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Cardinal Health Nuclear Medicine Imaging Agents Product Portfolio Table 124. Cardinal Health Recent Development Table 125. Bracco Diagnostic Company Information Table 126. Bracco Diagnostic Business Overview Table 127. Bracco Diagnostic Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolio Table 129. Bracco Diagnostic Recent Development Table 130. Blue Earth Diagnostics Company Information Table 131. Blue Earth Diagnostics Business Overview Table 132. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolio Table 134. Blue Earth Diagnostics Recent Development Table 135. Bayer AG Company Information Table 136. Bayer AG Business Overview Table 137. Bayer AG Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Bayer AG Nuclear Medicine Imaging Agents Product Portfolio Table 139. Bayer AG Recent Development Table 140. Abx Advanced Biochemical Company Information Table 141. Abx Advanced Biochemical Business Overview Table 142. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolio Table 144. Abx Advanced Biochemical Recent Development Table 145. North America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. North America Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 147. North America Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026) Table 148. North America Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units) Table 149. North America Nuclear Medicine Imaging Agents Sales Market Share Forecast by Country (2027-2032) Table 150. North America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. North America Nuclear Medicine Imaging Agents Market Size by Country (2021-2026) & (US$ Million) Table 152. North America Nuclear Medicine Imaging Agents Market Share by Country (2021-2026) Table 153. North America Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. North America Nuclear Medicine Imaging Agents Market Share Forecast by Country (2027-2032) Table 155. Europe Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 157. Europe Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026) Table 158. Europe Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units) Table 159. Europe Nuclear Medicine Imaging Agents Sales Market Share Forecast by Country (2027-2032) Table 160. Europe Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Europe Nuclear Medicine Imaging Agents Market Size by Country (2021-2026) & (US$ Million) Table 162. Europe Nuclear Medicine Imaging Agents Market Share by Country (2021-2026) Table 163. Europe Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Europe Nuclear Medicine Imaging Agents Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 167. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026) Table 168. Asia-Pacific Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units) Table 169. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share Forecast by Country (2027-2032) Table 170. Asia-Pacific Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Country (2021-2026) & (US$ Million) Table 172. Asia-Pacific Nuclear Medicine Imaging Agents Market Share by Country (2021-2026) Table 173. Asia-Pacific Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Asia-Pacific Nuclear Medicine Imaging Agents Market Share Forecast by Country (2027-2032) Table 175. Latin America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. Latin America Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 177. Latin America Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026) Table 178. Latin America Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units) Table 179. Latin America Nuclear Medicine Imaging Agents Sales Market Share Forecast by Country (2027-2032) Table 180. Latin America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Latin America Nuclear Medicine Imaging Agents Market Size by Country (2021-2026) & (US$ Million) Table 182. Latin America Nuclear Medicine Imaging Agents Market Share by Country (2021-2026) Table 183. Latin America Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Latin America Nuclear Medicine Imaging Agents Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026) & (K Units) Table 187. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share by Country (2021-2026) Table 188. Middle East and Africa Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032) & (K Units) Table 189. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share Forecast by Country (2027-2032) Table 190. Middle East and Africa Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Middle East and Africa Nuclear Medicine Imaging Agents Market Size by Country (2021-2026) & (US$ Million) Table 192. Middle East and Africa Nuclear Medicine Imaging Agents Market Share by Country (2021-2026) Table 193. Middle East and Africa Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Middle East and Africa Nuclear Medicine Imaging Agents Market Share Forecast by Country (2027-2032) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Nuclear Medicine Imaging Agents Distributors List Table 198. Nuclear Medicine Imaging Agents Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Nuclear Medicine Imaging Agents Image Figure 2. Global Nuclear Medicine Imaging Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Imaging Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Medicine Imaging Agents Sales (2021-2032) & (K Units) Figure 5. Nitrogen 13 Labeling Image Figure 6. Global Nitrogen 13 Labeling Sales YoY Growth (2021-2032) & (K Units) Figure 7. Technetium 99 Labeling Image Figure 8. Global Technetium 99 Labeling Sales YoY Growth (2021-2032) & (K Units) Figure 9. Fluorine 18 Labeling Image Figure 10. Global Fluorine 18 Labeling Sales YoY Growth (2021-2032) & (K Units) Figure 11. Carbon 11 Labeling Image Figure 12. Global Carbon 11 Labeling Sales YoY Growth (2021-2032) & (K Units) Figure 13. Oxygen 15 Labeling Image Figure 14. Global Oxygen 15 Labeling Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Nuclear Medicine Imaging Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Nuclear Medicine Imaging Agents Market Share by Type 2025 VS 2032 Figure 19. North America Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type in 2025 Figure 20. North America Nuclear Medicine Imaging Agents Sales Market Share in Value by Type in 2025 Figure 21. Europe Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type in 2025 Figure 22. Europe Nuclear Medicine Imaging Agents Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share in Value by Type in 2025 Figure 25. Latin America Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Nuclear Medicine Imaging Agents Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Nuclear Medicine Imaging Agents Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Clinical Stage Image Figure 32. Global Clinical Stage Sales YoY Growth (2021-2032) & (K Units) Figure 33. Early Diagnosis Image Figure 34. Global Early Diagnosis Sales YoY Growth (2021-2032) & (K Units) Figure 35. Treatment Evaluation Image Figure 36. Global Treatment Evaluation Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Nuclear Medicine Imaging Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Nuclear Medicine Imaging Agents Market Share by Application 2025 VS 2032 Figure 39. North America Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application in 2025 Figure 40. North America Nuclear Medicine Imaging Agents Sales Market Share in Value by Application in 2025 Figure 41. Europe Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application in 2025 Figure 42. Europe Nuclear Medicine Imaging Agents Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Nuclear Medicine Imaging Agents Sales Market Share in Value by Application in 2025 Figure 45. Latin America Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Nuclear Medicine Imaging Agents Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Nuclear Medicine Imaging Agents Sales Market Share in Value by Application in 2025 Figure 49. North America Nuclear Medicine Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Nuclear Medicine Imaging Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Nuclear Medicine Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Nuclear Medicine Imaging Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Nuclear Medicine Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Nuclear Medicine Imaging Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Nuclear Medicine Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Nuclear Medicine Imaging Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Nuclear Medicine Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Nuclear Medicine Imaging Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Nuclear Medicine Imaging Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Nuclear Medicine Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Nuclear Medicine Imaging Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Nuclear Medicine Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Nuclear Medicine Imaging Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Nuclear Medicine Imaging Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Nuclear Medicine Imaging Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Nuclear Medicine Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Nuclear Medicine Imaging Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Nuclear Medicine Imaging Agents Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Nuclear Medicine Imaging Agents Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Nitrogen 13 Labeling
  • Technetium 99 Labeling
  • Fluorine 18 Labeling
  • Carbon 11 Labeling
  • Oxygen 15 Labeling
  • Others
Applications
  • Clinical Stage
  • Early Diagnosis
  • Treatment Evaluation
Companies covered
  • Jubilant Pharma Limited
  • Foshan Rui Diao Pharmaceutical
  • Yantai Dongcheng
  • Navidea
  • Mallinckrodt
  • Lantheus
  • Guerbet
  • GE HealthCare
  • Eli Lilly and Company
  • Cardinal Health
  • Bracco Diagnostic
  • Blue Earth Diagnostics
  • Bayer AG
  • Abx Advanced Biochemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nuclear Medicine Imaging Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nuclear Medicine Imaging Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nuclear Medicine Imaging Agents Market by Type
  6. 1.3.1 Nitrogen 13 Labeling
  7. 1.3.2 Technetium 99 Labeling
  8. 1.3.3 Fluorine 18 Labeling
  9. 1.3.4 Carbon 11 Labeling
  10. 1.3.5 Oxygen 15 Labeling
  11. 1.3.6 Others
  12. 1.4 Global Nuclear Medicine Imaging Agents Market Size by Type
  13. 1.4.1 Global Nuclear Medicine Imaging Agents Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Nuclear Medicine Imaging Agents Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Nuclear Medicine Imaging Agents Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Nuclear Medicine Imaging Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Nuclear Medicine Imaging Agents Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Nuclear Medicine Imaging Agents Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Nuclear Medicine Imaging Agents Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Nuclear Medicine Imaging Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nuclear Medicine Imaging Agents Industry Trends
  2. 2.2 Nuclear Medicine Imaging Agents Industry Drivers
  3. 2.3 Nuclear Medicine Imaging Agents Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Imaging Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nuclear Medicine Imaging Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Nuclear Medicine Imaging Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Nuclear Medicine Imaging Agents Price (2021-2026)
  4. 3.4 Global Nuclear Medicine Imaging Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclear Medicine Imaging Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Nuclear Medicine Imaging Agents Company, Product Type & Application
  7. 3.7 Global Nuclear Medicine Imaging Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclear Medicine Imaging Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclear Medicine Imaging Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclear Medicine Imaging Agents Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine Imaging Agents Regional Status and Outlook
  1. 4.1 Global Nuclear Medicine Imaging Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nuclear Medicine Imaging Agents Historic Market Size by Region
  3. 4.2.1 Global Nuclear Medicine Imaging Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nuclear Medicine Imaging Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nuclear Medicine Imaging Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nuclear Medicine Imaging Agents Forecasted Market Size by Region
  7. 4.3.1 Global Nuclear Medicine Imaging Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nuclear Medicine Imaging Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nuclear Medicine Imaging Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nuclear Medicine Imaging Agents by Application
  1. 5.1 Nuclear Medicine Imaging Agents Market by Application
  2. 5.1.1 Clinical Stage
  3. 5.1.2 Early Diagnosis
  4. 5.1.3 Treatment Evaluation
  5. 5.2 Global Nuclear Medicine Imaging Agents Market Size by Application
  6. 5.2.1 Global Nuclear Medicine Imaging Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nuclear Medicine Imaging Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nuclear Medicine Imaging Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nuclear Medicine Imaging Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nuclear Medicine Imaging Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nuclear Medicine Imaging Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nuclear Medicine Imaging Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nuclear Medicine Imaging Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jubilant Pharma Limited
  2. 6.1.1 Jubilant Pharma Limited Company Information
  3. 6.1.2 Jubilant Pharma Limited Business Overview
  4. 6.1.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Product Portfolio
  6. 6.1.5 Jubilant Pharma Limited Recent Developments
  7. 6.2 Foshan Rui Diao Pharmaceutical
  8. 6.2.1 Foshan Rui Diao Pharmaceutical Company Information
  9. 6.2.2 Foshan Rui Diao Pharmaceutical Business Overview
  10. 6.2.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Product Portfolio
  12. 6.2.5 Foshan Rui Diao Pharmaceutical Recent Developments
  13. 6.3 Yantai Dongcheng
  14. 6.3.1 Yantai Dongcheng Company Information
  15. 6.3.2 Yantai Dongcheng Business Overview
  16. 6.3.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Product Portfolio
  18. 6.3.5 Yantai Dongcheng Recent Developments
  19. 6.4 Navidea
  20. 6.4.1 Navidea Company Information
  21. 6.4.2 Navidea Business Overview
  22. 6.4.3 Navidea Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Navidea Nuclear Medicine Imaging Agents Product Portfolio
  24. 6.4.5 Navidea Recent Developments
  25. 6.5 Mallinckrodt
  26. 6.5.1 Mallinckrodt Company Information
  27. 6.5.2 Mallinckrodt Business Overview
  28. 6.5.3 Mallinckrodt Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mallinckrodt Nuclear Medicine Imaging Agents Product Portfolio
  30. 6.5.5 Mallinckrodt Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lantheus Nuclear Medicine Imaging Agents Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 Guerbet
  38. 6.7.1 Guerbet Company Information
  39. 6.7.2 Guerbet Business Overview
  40. 6.7.3 Guerbet Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Guerbet Nuclear Medicine Imaging Agents Product Portfolio
  42. 6.7.5 Guerbet Recent Developments
  43. 6.8 GE HealthCare
  44. 6.8.1 GE HealthCare Company Information
  45. 6.8.2 GE HealthCare Business Overview
  46. 6.8.3 GE HealthCare Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GE HealthCare Nuclear Medicine Imaging Agents Product Portfolio
  48. 6.8.5 GE HealthCare Recent Developments
  49. 6.9 Eli Lilly and Company
  50. 6.9.1 Eli Lilly and Company Company Information
  51. 6.9.2 Eli Lilly and Company Business Overview
  52. 6.9.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Product Portfolio
  54. 6.9.5 Eli Lilly and Company Recent Developments
  55. 6.10 Cardinal Health
  56. 6.10.1 Cardinal Health Company Information
  57. 6.10.2 Cardinal Health Business Overview
  58. 6.10.3 Cardinal Health Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cardinal Health Nuclear Medicine Imaging Agents Product Portfolio
  60. 6.10.5 Cardinal Health Recent Developments
  61. 6.11 Bracco Diagnostic
  62. 6.11.1 Bracco Diagnostic Company Information
  63. 6.11.2 Bracco Diagnostic Business Overview
  64. 6.11.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Product Portfolio
  66. 6.11.5 Bracco Diagnostic Recent Developments
  67. 6.12 Blue Earth Diagnostics
  68. 6.12.1 Blue Earth Diagnostics Company Information
  69. 6.12.2 Blue Earth Diagnostics Business Overview
  70. 6.12.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Product Portfolio
  72. 6.12.5 Blue Earth Diagnostics Recent Developments
  73. 6.13 Bayer AG
  74. 6.13.1 Bayer AG Company Information
  75. 6.13.2 Bayer AG Business Overview
  76. 6.13.3 Bayer AG Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bayer AG Nuclear Medicine Imaging Agents Product Portfolio
  78. 6.13.5 Bayer AG Recent Developments
  79. 6.14 Abx Advanced Biochemical
  80. 6.14.1 Abx Advanced Biochemical Company Information
  81. 6.14.2 Abx Advanced Biochemical Business Overview
  82. 6.14.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Product Portfolio
  84. 6.14.5 Abx Advanced Biochemical Recent Developments
7 North America by Country
  1. 7.1 North America Nuclear Medicine Imaging Agents Sales by Country
  2. 7.1.1 North America Nuclear Medicine Imaging Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nuclear Medicine Imaging Agents Market Size by Country
  6. 7.2.1 North America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nuclear Medicine Imaging Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nuclear Medicine Imaging Agents Sales by Country
  2. 8.1.1 Europe Nuclear Medicine Imaging Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nuclear Medicine Imaging Agents Market Size by Country
  6. 8.2.1 Europe Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nuclear Medicine Imaging Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales by Country
  2. 9.1.1 Asia-Pacific Nuclear Medicine Imaging Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nuclear Medicine Imaging Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nuclear Medicine Imaging Agents Sales by Country
  2. 10.1.1 South America Nuclear Medicine Imaging Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nuclear Medicine Imaging Agents Market Size by Country
  6. 10.2.1 South America Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nuclear Medicine Imaging Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nuclear Medicine Imaging Agents Sales by Country
  2. 11.1.1 Middle East and Africa Nuclear Medicine Imaging Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nuclear Medicine Imaging Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nuclear Medicine Imaging Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nuclear Medicine Imaging Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Nuclear Medicine Imaging Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nuclear Medicine Imaging Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nuclear Medicine Imaging Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nuclear Medicine Imaging Agents Value Chain Analysis
  2. 12.1.1 Nuclear Medicine Imaging Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nuclear Medicine Imaging Agents Production Mode & Process
  7. 12.2 Nuclear Medicine Imaging Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nuclear Medicine Imaging Agents Distributors
  10. 12.2.3 Nuclear Medicine Imaging Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst